FDA announces Class I recall of battery packs for intra-aortic balloon pumps

Michael Walter | | Cardiovascular Business | Acute Coronary Syndromes
Recall | Product recall

The FDA has announced that Datascope/Getinge/Maquet are recalling certain battery packs for the Cardiosave Hybrid and Rescue intra-aortic balloon pumps due to the batteries failing much quicker than originally advertised.

These devices are typically used when patients are undergoing surgery—cardiac or otherwise—or when they present with acute coronary syndromes or complications related to heart failure.

This is a Class I recall, meaning the use of these devices “may cause serious injuries or death.” There have been six total complaints about the issue at this time, but no injuries or deaths.

“If a patient requires life-supporting therapy with an intra-aortic balloon pump and the device does not work or if therapy is stopped during use due to battery failure, the patient will be at risk of serious injury, including death,” according to the FDA’s advisory.

The battery packs being recalled were distributed to customers from September 2017 to August 2021. The recall was first initiated on Sept. 21, 2021.

The full FDA advisory is available here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
IVUS-guided PCI reduces risks in patients with diabetes
Predicting sudden cardiac death after a heart attack may be impossible—for now
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."